USB
AZN icon

Union Savings Bank’s AstraZeneca AZN Stock Holding History

Union Savings Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84K Hold
15
– – ﹤0.01% 300
2026
Q1 		$2.96K Hold
15
– – ﹤0.01% 299
2025
Q4 		$2.76K Buy
+15
New +$2.63K ﹤0.01% 308

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Union Savings Bank's AZN Position: Q2 2026 in Review

Union Savings Bank held its AstraZeneca (AZN) position steady in Q2 2026 at 15 shares worth $2.84K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

Union Savings Bank first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.96K in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Union Savings Bank held 15 shares of AstraZeneca worth $2.84K as of Q2 2026.
  • Union Savings Bank left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Union Savings Bank's portfolio in Q2 2026, its #300 holding.
  • Union Savings Bank first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Union Savings Bank's AstraZeneca position peaked at $2.96K in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.